All Stories

  1. The changing epidemiology of outbreaks due to Ralstonia spp .: contamination of commercially manufactured injectables and solutions

    Article • Infection Control, September 2026, Cambridge University Press

    Dr Allison McGeer

  2. Dominance of the ST20 stG62647 Lineage Among Invasive Streptococcus dysgalactiae subsp. equisimilis Infections in Toronto, Canada

    Article • Microorganisms, April 2026, MDPI AG

    Dr Allison McGeer

  3. Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemic Streptococcus pyogenes M1 UK

    Article • Infection and Immunity, February 2026, ASM Journals

    Dr Allison McGeer

  4. Post-Licensure Safety of Nirsevimab from the Canadian National Vaccine Safety (CANVAS) Network

    Article • August 2025, Cold Spring Harbor Laboratory Press

    Dr Allison McGeer

  5. Using behavioural science to improve antibiotic stewardship in Canadian long-term care homes: Protocol for a multi-center cluster randomized quality improvement study

    Article • Canada Communicable Disease Report, January 2025, Infectious Disease and Control Branc (IDPCB) - Public Health Agency of Canada

    Dr Allison McGeer

  6. SARS-CoV-2 burden on the floor was associated with COVID-19 cases and outbreaks in two acute care hospitals: a prospective cohort study

    Article • Infection Control, September 2024, Cambridge University Press

    Dr Allison McGeer

  7. Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study

    Article • Vaccine, January 2024, Elsevier

    Dr Allison McGeer

  8. Assessing a safety climate tool adapted to address respiratory illnesses in Canadian hospitals

    Article • Antimicrobial Stewardship & Healthcare Epidemiology, January 2024, Cambridge University Press

    Dr Allison McGeer

  9. Use of whole genome sequencing to identify low‐frequency mutations in SARS‐CoV‐2 patients treated with remdesivir

    Article • Influenza and Other Respiratory Viruses, September 2023, Wiley

    Dr Allison McGeer

  10. Natural Language Processing for Clinical Laboratory Data Repository Systems: Implementation and Evaluation for Respiratory Viruses

    Article • JMIR AI, June 2023, JMIR Publications Inc.

    Dr Allison McGeer

  11. The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort study

    Article • Journal of Medical Economics, February 2023, Taylor & Francis

    Dr Allison McGeer

  12. Natural Language Processing for Clinical Laboratory Data Repository Systems: Implementation and Evaluation for Respiratory Viruses (Preprint)

    Article • December 2022, JMIR Publications Inc.

    Dr Allison McGeer

  13. Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir

    Article • November 2022, Cold Spring Harbor Laboratory Press

    Dr Allison McGeer

  14. Severity of Omicron SARS-CoV-2 Infection in Vaccinated and Unvaccinated Residents of Long Term Care Homes

    Article • Infection Control, May 2022, Cambridge University Press

    Dr Allison McGeer

  15. Burden of severe illness associated with laboratory confirmed influenza in adults aged 50–64 years: A rapid review

    Article • Influenza and Other Respiratory Viruses, January 2022, Wiley

    Dr Allison McGeer

  16. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study

    Article • Infection Control, October 2020, Cambridge University Press

    Dr Allison McGeer, Dr Christian R Kahlert

  17. Frequency of hand hygiene opportunities in patients on a general surgery service

    Article • American Journal of Infection Control, May 2020, Elsevier

    Dr Allison McGeer

  18. Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital

    Article • PLOS One, February 2019, PLOS

    Dr Allison McGeer

  19. N o 225-Lignes directrices quant à la prise en charge des patientes en obstétrique chez lesquelles la présence du syndrome respiratoire aigu sévère (SRAS) est soupçonnée ou probable, et des nouveau-nés issus de ces patientes

    Article • Journal of Obstetrics and Gynaecology Canada, August 2017, Elsevier

    Dr Allison McGeer

  20. No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)

    Article • Journal of Obstetrics and Gynaecology Canada, August 2017, Elsevier

    Dr Allison McGeer

  21. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study

    Article • Vaccine, June 2017, Elsevier

    Dr Allison McGeer

  22. Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing

    Article • PLOS One, May 2017, PLOS

    Dr Allison McGeer

  23. Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05–2013/14, Toronto, Canada

    Article • Antiviral Research, April 2017, Elsevier

    Dr Allison McGeer

  24. Detecting and quantifying influenza virus with self- versus investigator-collected mid-turbinate nasal swabs

    Article • Journal of Medical Virology, February 2017, Wiley

    Dr Allison McGeer

  25. Optimal hand washing technique to minimize bacterial contamination before neuraxial anesthesia: a randomized control trial

    Article • International Journal of Obstetric Anesthesia, February 2017, Elsevier

    Dr Allison McGeer

  26. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2017, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  27. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2017, Springer Science + Business Media

    Dr Allison McGeer

  28. Active Surveillance for Influenza Reduces but Does Not Eliminate Hospital Exposure to Patients With Influenza

    Article • Infection Control, January 2017, Cambridge University Press

    Dr Allison McGeer

  29. Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections

    Article • Journal of Clinical Virology, January 2017, Elsevier

    Dr Allison McGeer

  30. Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Dr Allison McGeer

  31. Unit-Specific Rates of Hand Hygiene Opportunities in an Acute-Care Hospital

    Article • Infection Control, December 2016, Cambridge University Press

    Dr Allison McGeer

  32. High Incidence of Invasive group A Streptococcal Infections in Remote Indigenous Communities in Northwestern Ontario, Canada.

    Article • Open Forum Infectious Diseases, December 2016, Oxford University Press (OUP)

    Dr Allison McGeer

  33. Serotype Distribution, Population Structure, and Antimicrobial Resistance of Group B Streptococcus Strains Recovered from Colonized Pregnant Women

    Article • Journal of Clinical Microbiology, November 2016, ASM Journals

    Dr Allison McGeer

  34. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for RecurrentClostridium difficileInfection: An Open-Label, Randomized Controlled Trial

    Article • Clinical Infectious Diseases, November 2016, Oxford University Press (OUP)

    Dr Allison McGeer

  35. Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Strains: An Investigation Into Household Transmission, Risk Factors, and Environmental Contamination

    Article • Infection Control, November 2016, Cambridge University Press

    Dr Allison McGeer

  36. Acquisition of bacteria on health care workers' hands after contact with patient privacy curtains

    Article • American Journal of Infection Control, November 2016, Elsevier

    Dr Allison McGeer

  37. Capsular Switching and Other Large-Scale Recombination Events in Invasive Sequence Type 1 Group BStreptococcus

    Article • Emerging Infectious Diseases, November 2016, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  38. Predictors of influenza among older adults in the emergency department

    Article • BMC Infectious Diseases, October 2016, Springer Science + Business Media

    Dr Allison McGeer

  39. The Effect of Hospital Isolation Precautions on Patient Outcomes and Cost of Care: A Multi-Site, Retrospective, Propensity Score-Matched Cohort Study

    Article • Journal of General Internal Medicine, October 2016, Springer Science + Business Media

    Dr Allison McGeer

  40. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study

    Article • The American Journal of Gastroenterology, May 2016, Nature

    Dr Allison McGeer

  41. Clonal Complex 17 Group B Streptococcus strains causing invasive disease in neonates and adults originate from the same genetic pool

    Article • Scientific Reports, February 2016, Nature

    Dr Roberto G Melano, Dr Allison McGeer

  42. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis

    Article • Influenza and Other Respiratory Viruses, February 2016, Wiley

    Dr Allison McGeer, Kamran Lankarani, Dr CATIA CILLONIZ, Jordi Carratalà

  43. Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003–2011

    Article • Vaccine, February 2016, Elsevier

    Dr Allison McGeer

  44. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012

    Article • Infection Control, January 2016, Cambridge University Press

    Dr Allison McGeer

  45. Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review

    Article • Journal of Hospital Infection, January 2016, Elsevier

    Dr Allison McGeer

  46. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Dr Roberto G Melano, Dr Allison McGeer

  47. Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers

    Article • Vaccine, November 2015, Elsevier

    Dr Allison McGeer

  48. High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of UncommonemmTypes in Thunder Bay, Ontario, Canada

    Article • Journal of Clinical Microbiology, October 2015, ASM Journals

    Dr Allison McGeer

  49. Vancomycin-Variable Enterococcal Bacteremia

    Article • Journal of Clinical Microbiology, September 2015, ASM Journals

    Dr Allison McGeer

  50. Epidemiological features of influenza in Canadian adult intensive care unit patients

    Article • Epidemiology and Infection, September 2015, Cambridge University Press

    Dr Geoffrey Taylor, Dr Allison McGeer

  51. Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns

    Article • Human Vaccines & Immunotherapeutics, September 2015, Taylor & Francis

    Dr Allison McGeer

  52. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs

    Article • Clinical Infectious Diseases, September 2015, Oxford University Press (OUP)

    Dr Allison McGeer

  53. Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort

    Article • Clinical Infectious Diseases, September 2015, Oxford University Press (OUP)

    Dr Allison McGeer

  54. Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains

    Article • Journal of Clinical Microbiology, July 2015, ASM Journals

    Dr Roberto G Melano, Dr Allison McGeer

  55. Examining Perceptions about Mandatory Influenza Vaccination of Healthcare Workers through Online Comments on News Stories

    Article • PLOS One, June 2015, PLOS

    Dr Allison McGeer

  56. Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012

    Article • Clinical Microbiology and Infection, June 2015, Elsevier

    Dr Allison McGeer

  57. Sequence type 1 group B Streptococcus , an emerging cause of invasive disease in adults, evolves by small genetic changes

    Article • Proceedings of the National Academy of Sciences, May 2015, Proceedings of the National Academy of Sciences

    Dr Anthony R Flores, Dr Allison McGeer

  58. Middle East respiratory syndrome

    Article • Canadian Medical Association Journal, April 2015, Canadian Medical Association (CMA)

    Dr Allison McGeer

  59. Population Structure and Antimicrobial Resistance of Invasive Serotype IV Group B Streptococcus , Toronto, Ontario, Canada

    Article • Emerging Infectious Diseases, April 2015, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer, Dr Roberto G Melano

  60. Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Canadian Tertiary Cancer Center Experience

    Article • Infection Control, February 2015, Cambridge University Press

    Dr Allison McGeer

  61. Simulation Study of the Effect of Influenza and Influenza Vaccination on Risk of Acquiring Guillain-Barré Syndrome

    Article • Emerging Infectious Diseases, February 2015, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  62. Protecting the Frontline: Designing an Infection Prevention Platform for Preventing Emerging Respiratory Viral Illnesses in Healthcare Personnel

    Article • Infection Control, January 2015, Cambridge University Press

    Dr Allison McGeer

  63. Zanamivir versus trivalent split virus influenza vaccine: a pilot randomized trial

    Article • Influenza and Other Respiratory Viruses, January 2015, Wiley

    Dr Allison McGeer

  64. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: A cluster randomized trial

    Article • Vaccine, January 2015, Elsevier

    Dr Allison McGeer

  65. Vancomycin-Variable Enterococci Can Give Rise to Constitutive Resistance during Antibiotic Therapy

    Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

    Dr Allison McGeer

  66. Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study

    Article • BMC Infectious Diseases, December 2014, Springer Science + Business Media

    Dr Allison McGeer

  67. Reply to Vanhems et al

    Article • Infection Control, August 2014, Cambridge University Press

    Dr Allison McGeer

  68. In Vitro Activity of New Cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008–2011

    Article • Current Microbiology, July 2014, Springer Science + Business Media

    Dr Allison McGeer

  69. Previous Antibiotic Exposure and Antimicrobial Resistance in Invasive Pneumococcal Disease: Results From Prospective Surveillance

    Article • Clinical Infectious Diseases, June 2014, Oxford University Press (OUP)

    Dr Allison McGeer

  70. External cues to action and influenza vaccination among post-graduate trainee physicians in Toronto, Canada

    Article • Vaccine, June 2014, Elsevier

    Dr Allison McGeer

  71. Reply to Chironda et al

    Article • Clinical Infectious Diseases, May 2014, Oxford University Press (OUP)

    Dr Allison McGeer

  72. Health care workers, mandatory influenza vaccination policies and the law

    Article • Canadian Medical Association Journal, May 2014, Canadian Medical Association (CMA)

    Dr Allison McGeer

  73. A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

    Article • The Journal of Infectious Diseases, May 2014, Oxford University Press (OUP)

    Professor ANDROULLA EFSTRATIOU, Dr Allison McGeer

  74. The integration of barcode scanning technology into Canadian public health immunization settings

    Article • Vaccine, May 2014, Elsevier

    Dr Allison McGeer

  75. Influenza vaccination and Guillain-Barré syndrome

    Article • The Lancet Infectious Diseases, May 2014, Elsevier

    Dr Allison McGeer

  76. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

    Article • The Lancet Respiratory Medicine, May 2014, Elsevier

    Dr Allison McGeer, Dr CATIA CILLONIZ, Kamran Lankarani, Jordi Carratalà

  77. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences

    Article • Proceedings of the National Academy of Sciences, April 2014, Proceedings of the National Academy of Sciences

    Dr Scott W Long, Dr Allison McGeer

  78. The Reemergence of Severe Group A Streptococcal Disease: an Evolutionary Perspective

    Article • April 2014, ASM Journals

    Dr Allison McGeer

  79. Medusa's Ugly Head Again: From SARS to MERS-CoV

    Article • Annals of Internal Medicine, March 2014, American College of Physicians

    Dr Allison McGeer

  80. Rate of Healthcare Worker–Patient Interaction and Hand Hygiene Opportunities in an Acute Care Setting

    Article • Infection Control, March 2014, Cambridge University Press

    Dr Allison McGeer

  81. Reducing Antimicrobial Therapy for Asymptomatic Bacteriuria Among Noncatheterized Inpatients: A Proof-of-Concept Study

    Article • Clinical Infectious Diseases, February 2014, Oxford University Press (OUP)

    Dr Allison McGeer

  82. Characterization of Invasive Group B Streptococcus Strains from the Greater Toronto Area, Canada

    Article • Journal of Clinical Microbiology, February 2014, ASM Journals

    Dr Allison McGeer

  83. Outbreak of Vancomycin-Susceptible Enterococcus faecium Containing the Wild-Type vanA Gene

    Article • Journal of Clinical Microbiology, February 2014, ASM Journals

    Dr Allison McGeer

  84. Vancomycin-Variable Enterococcus faecium: In Vivo Emergence of Vancomycin Resistance in a Vancomycin-Susceptible Isolate

    Article • Journal of Clinical Microbiology, February 2014, ASM Journals

    Dr Allison McGeer

  85. Peripartum outcomes: non-adjuvanted v. adjuvanted H1N1 vaccination

    Article • Canadian Medical Association Journal, February 2014, Canadian Medical Association (CMA)

    Dr Allison McGeer

  86. Healthcare-Associated Influenza in Canadian Hospitals from 2006 to 2012

    Article • Infection Control, February 2014, Cambridge University Press

    Dr Allison McGeer

  87. Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic

    Article • Antimicrobial Resistance and Infection Control, January 2014, Springer Science + Business Media

    Dr Allison McGeer

  88. Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole

    Article • PLOS One, January 2014, PLOS

    Dr Mark Miller, Dr Allison McGeer, Gerald Evans

  89. The Effect of Gowning on Labor Epidural Catheter Colonization Rate

    Article • Regional Anesthesia & Pain Medicine, January 2014, Wolters Kluwer Health

    Dr Allison McGeer

  90. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011

    Article • Vaccine, December 2013, Elsevier

    Dr Allison McGeer

  91. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

    Article • Canadian Journal of Microbiology, December 2013, Canadian Science Publishing

    Dr Allison McGeer

  92. Complete sequences of a novel blaNDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada

    Article • Journal of Antimicrobial Chemotherapy, November 2013, Oxford University Press (OUP)

    Dr Mark Miller, Dr Allison McGeer

  93. Understanding the burden of influenza infection among adults in Canadian hospitals: A comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons

    Article • American Journal of Infection Control, November 2013, Elsevier

    Dr Allison McGeer

  94. In Memoriam

    Article • Critical Care Clinics, October 2013, Elsevier

    Dr Allison McGeer

  95. Downstream Impact of Urine Cultures Ordered without Indication at Two Acute Care Teaching Hospitals

    Article • Infection Control, October 2013, Cambridge University Press

    Dr Allison McGeer

  96. Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals

    Article • PLOS One, September 2013, PLOS

    Dr Allison McGeer

  97. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study

    Article • The Lancet Infectious Diseases, September 2013, Elsevier

    Dr Allison McGeer

  98. Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer, Dr Matthew L Cotten

  99. Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study

    Article • BMC Infectious Diseases, July 2013, Springer Science + Business Media

    Dr Allison McGeer

  100. Prevalence of Colonization and Infection with Methicillin-ResistantStaphylococcus aureusand Vancomycin-ResistantEnterococcusand ofClostridium difficileInfection in Canadian Hospitals

    Article • Infection Control, July 2013, Cambridge University Press

    Dr Allison McGeer

  101. The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated With 2009 Influenza A(H1N1) Infection

    Article • CHEST Journal, July 2013, Elsevier

    Dr Allison McGeer, Dr Philippe Andre Jouvet

  102. Contamination of Canadian private drinking water sources with antimicrobial resistant Escherichia coli

    Article • Water Research, June 2013, Elsevier

    Dr Allison McGeer

  103. Have changing pneumococcal vaccination programmes impacted disease in Ontario?

    Article • Vaccine, May 2013, Elsevier

    Dr Allison McGeer

  104. Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae

    Article • PLOS One, April 2013, PLOS

    Dr Allison McGeer

  105. Cardiac complications of influenza infection in 3 adults

    Article • Canadian Medical Association Journal, April 2013, Canadian Medical Association (CMA)

    Dr Allison McGeer

  106. Measuring influenza immunization coverage among health care workers in acute care hospitals and continuing care organizations in Canada

    Article • American Journal of Infection Control, April 2013, Elsevier

    Dr Allison McGeer

  107. Risk Factors for Influenza among Health Care Workers during 2009 Pandemic, Toronto, Ontario, Canada

    Article • Emerging Infectious Diseases, April 2013, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  108. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009

    Article • Journal of Antimicrobial Chemotherapy, March 2013, Oxford University Press (OUP)

    Dr Allison McGeer, Gerald Evans

  109. Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant

    Article • Leukemia & Lymphoma, January 2013, Taylor & Francis

    Dr Allison McGeer

  110. Behind the mask: Determinants of nurse's adherence to facial protective equipment

    Article • American Journal of Infection Control, January 2013, Elsevier

    Dr Allison McGeer

  111. An observational study of the hand hygiene initiative: a comparison of preintervention and postintervention outcomes

    Article • BMJ Open, January 2013, BMJ

    Dr Allison McGeer

  112. Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada

    Article • Influenza and Other Respiratory Viruses, November 2012, Wiley

    Dr Allison McGeer

  113. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae

    Article • American Journal of Infection Control, November 2012, Elsevier

    Dr Allison McGeer

  114. Maternal Antibiotic Exposure and Risk of Antibiotic Resistance in Neonatal Early-onset Sepsis

    Article • The Pediatric Infectious Disease Journal, November 2012, Wolters Kluwer Health

    Dr Allison McGeer

  115. Laboratory-Confirmed Pandemic H1N1 Influenza in Hospitalized Adults: Findings from the Canadian Nosocomial Infections Surveillance Program, 2009-2010

    Article • Infection Control, October 2012, Cambridge University Press

    Dr Allison McGeer

  116. Outbreak of Carbapenem-Resistant Enterobacteriaceae Containing blaNDM-1, Ontario, Canada

    Article • Clinical Infectious Diseases, September 2012, Oxford University Press (OUP)

    Dr Roberto G Melano, Dr Allison McGeer

  117. The Impact of Infection on Population Health: Results of the Ontario Burden of Infectious Diseases Study

    Article • PLOS One, September 2012, PLOS

    Dr Allison McGeer

  118. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine

    Article • Vaccine, September 2012, Elsevier

    Dr Allison McGeer

  119. The Social Determinants of Health and Pandemic H1N1 2009 Influenza Severity

    Article • American Journal of Public Health, August 2012, American Public Health Association

    Dr Allison McGeer

  120. Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population

    Article • Journal of Crohn s and Colitis, August 2012, Oxford University Press (OUP)

    Dr Allison McGeer

  121. Outbreak of Extended-Spectrum β-Lactamase–producing Klebsiella oxytoca Infections Associated with Contaminated Handwashing Sinks1

    Article • Emerging Infectious Diseases, August 2012, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  122. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010

    Article • Canadian Journal of Microbiology, August 2012, Canadian Science Publishing

    Dr Allison McGeer

  123. Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine

    Article • PLOS One, July 2012, PLOS

    Dr Allison McGeer

  124. In Vitro Activity Of Ceftaroline And Comparative Agents Against Clinical Isolates Of Streptococcus Pneumoniae Collected From An Ongoing Canada Wide Surveillance Program: 2008 - 2011

    Article • May 2012, American Thoracic Society

    Dr Allison McGeer

  125. Decreased Susceptibility to Noncarbapenem Antimicrobials in Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Toronto, Canada

    Article • Antimicrobial Agents and Chemotherapy, April 2012, ASM Journals

    Dr Allison McGeer

  126. Emergency department visits and infections

    Article • Canadian Medical Association Journal, April 2012, Canadian Medical Association (CMA)

    Dr Allison McGeer

  127. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP)

    Article • Journal of Antimicrobial Chemotherapy, March 2012, Oxford University Press (OUP)

    Dr Allison McGeer

  128. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy a...

    Article • Vaccine, March 2012, Elsevier

    Dr Allison McGeer

  129. Risk of infection following a visit to the emergency department: a cohort study

    Article • Canadian Medical Association Journal, January 2012, Canadian Medical Association (CMA)

    Dr Allison McGeer

  130. Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009–May 2010

    Article • PLOS One, November 2011, PLOS

    Dr Allison McGeer

  131. Incidence of Influenza in Healthy Adults and Healthcare Workers: A Systematic Review and Meta-Analysis

    Article • PLOS One, October 2011, PLOS

    Dr Allison McGeer

  132. Another Look at the Human Papillomavirus Vaccine Experience in Canada

    Article • American Journal of Public Health, October 2011, American Public Health Association

    Dr Allison McGeer

  133. Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort study

    Article • European Journal of Clinical Microbiology & Infectious Diseases, July 2011, Springer Science + Business Media

    Dr Allison McGeer

  134. H1N1 in Pregnancy: A Tertiary Care Centre Experience

    Article • Journal of Obstetrics and Gynaecology Canada, July 2011, Elsevier

    Dr Allison McGeer

  135. Self-Collected Mid-Turbinate Swabs for the Detection of Respiratory Viruses in Adults with Acute Respiratory Illnesses

    Article • PLOS One, June 2011, PLOS

    Dr Allison McGeer, Professor Ralph A Tripp

  136. The role of drinking water in the transmission of antimicrobial-resistant E. coli

    Article • Epidemiology and Infection, June 2011, Cambridge University Press

    Dr Allison McGeer

  137. Evaluation of Coseasonality of Influenza and Invasive Pneumococcal Disease: Results from Prospective Surveillance

    Article • PLoS Medicine, June 2011, PLOS

    Dr Allison McGeer

  138. Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada

    Article • Antimicrobial Agents and Chemotherapy, May 2011, ASM Journals

    Dr Allison McGeer

  139. New Delhi metallo- -lactamase-1: local acquisition in Ontario, Canada, and challenges in detection

    Article • Canadian Medical Association Journal, May 2011, Canadian Medical Association (CMA)

    Dr Roberto G Melano, Dr Allison McGeer

  140. A Comparison Of The First And Second Waves Of H1N1-Related Critical Illness In Canada

    Article • May 2011, American Thoracic Society

    Dr Allison McGeer

  141. Prevalent And Incident Bacterial Infections Among Canadian Critically Ill Patients With Influenza A (H1N1) 2009- Preliminary Data

    Article • May 2011, American Thoracic Society

    Dr Allison McGeer

  142. Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season

    Article • Influenza and Other Respiratory Viruses, April 2011, Wiley

    Dr Allison McGeer

  143. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions

    Article • American Journal of Infection Control, April 2011, Elsevier

    Dr Allison McGeer, Dr Mark Miller

  144. Systemic Dysregulation of Angiopoietin-1 and -2 in Streptococcal Toxic Shock Syndrome

    Article • Clinical Infectious Diseases, April 2011, Oxford University Press (OUP)

    Dr Allison McGeer

  145. Distribution of Antiseptic Resistance GenesqacA, qacB, andsmrin Methicillin-Resistant Staphylococcus aureus Isolated in Toronto, Canada, from 2005 to 2009

    Article • Antimicrobial Agents and Chemotherapy, March 2011, ASM Journals

    Dr Roberto G Melano, Dr Allison McGeer

  146. Novel Mutations in a Patient Isolate of Streptococcus agalactiae with Reduced Penicillin Susceptibility Emerging after Long-Term Oral Suppressive Therapy

    Article • Antimicrobial Agents and Chemotherapy, March 2011, ASM Journals

    Dr Allison McGeer

  147. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness

    Article • Vaccine, February 2011, Elsevier

    Dr Allison McGeer

  148. Effect of Patterns of Transferring Patients among Healthcare Institutions on Rates of Nosocomial Methicillin-Resistant Staphylococcus aureus Transmission: A Monte Carlo Simulation

    Article • Infection Control, February 2011, Cambridge University Press

    Dr Allison McGeer

  149. New Delhi metallo- -lactamase-1 in Enterobacteriaceae: emerging resistance

    Article • Canadian Medical Association Journal, January 2011, Canadian Medical Association (CMA)

    Dr Allison McGeer

  150. 644: Knowledge about H1N1 influenza and the vaccine impacts vaccination uptake among pregnant women

    Article • American Journal of Obstetrics and Gynecology, January 2011, Elsevier

    Dr Allison McGeer

  151. When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto

    Article • Critical Care, January 2011, Springer Science + Business Media

    Dr Allison McGeer

  152. Predictors of pandemic influenza infection in adults presenting to two urban emergency departments, Toronto, 2009

    Article • Canadian Journal of Emergency Medicine, January 2011, Cambridge University Press

    Dr Allison McGeer

  153. Epidemic of Group A Streptococcus M/ emm 59 Causing Invasive Disease in Canada

    Article • Clinical Infectious Diseases, December 2010, Oxford University Press (OUP)

    Dr Allison McGeer

  154. Respiratory Virus Infection and Risk of Invasive Meningococcal Disease in Central Ontario, Canada

    Article • PLOS One, November 2010, PLOS

    Dr Allison McGeer

  155. Pandemic (H1N1) 2009: assessing the response

    Article • Canadian Medical Association Journal, October 2010, Canadian Medical Association (CMA)

    Dr Allison McGeer

  156. Physicians and hand hygiene practice: a focus group study

    Article • Journal of Hospital Infection, September 2010, Elsevier

    Dr Allison McGeer

  157. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience

    Article • Vaccine, August 2010, Elsevier

    Dr Allison McGeer

  158. Compulsory School-Entry Vaccination Laws and Exemptions: Who Is Opting Out in Ontario and Why Does It Matter?

    Article • Healthcare Policy | Politiques de Santé, May 2010, Longwoods Publishing

    Dr Allison McGeer

  159. Risk Factors for SARS Transmission from Patients Requiring Intubation: A Multicentre Investigation in Toronto, Canada

    Article • PLOS One, May 2010, PLOS

    Dr Allison McGeer

  160. Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8

    Article • European Journal of Clinical Microbiology & Infectious Diseases, April 2010, Springer Science + Business Media

    Dr Allison McGeer

  161. Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis

    Article • PLoS Medicine, April 2010, PLOS

    Dr Allison McGeer

  162. Laboratory diagnosis of 2009 H1N1 influenza A virus

    Article • Critical Care Medicine, April 2010, Wolters Kluwer Health

    Dr Allison McGeer

  163. Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007

    Article • Infection Control, April 2010, Cambridge University Press

    Dr Allison McGeer

  164. Hypervirulent Clostridium difficile Strains in Hospitalized Patients, Canada1

    Article • Emerging Infectious Diseases, April 2010, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer, Dr Mark Miller

  165. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates

    Article • Diagnostic Microbiology and Infectious Disease, April 2010, Elsevier

    Dr Allison McGeer, Dr Mark Miller

  166. Photonic Sensors: Towards the Photonic Nose: A Novel Platform for Molecule and Bacteria Identification (Adv. Mater. 12/2010)

    Article • Advanced Materials, March 2010, Wiley

    Dr Allison McGeer

  167. Review: Extended-duration chemoprophylaxis with neuraminidase inhibitors prevents symptomatic influenza

    Article • Annals of Internal Medicine, March 2010, American College of Physicians

    Dr Allison McGeer

  168. Antimicrobial Susceptibilities of Health Care-Associated and Community-Associated Strains of Methicillin-Resistant Staphylococcus aureus from Hospitalized Patients in Canada, 1995 to 2008

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Dr Allison McGeer

  169. Evaluation of Pneumonia Severity and Acute Physiology Scores to Predict ICU Admission and Mortality in Patients Hospitalized for Influenza

    Article • PLOS One, March 2010, PLOS

    Dr Allison McGeer

  170. Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics

    Article • Proceedings of the National Academy of Sciences, February 2010, Proceedings of the National Academy of Sciences

    Dr Allison McGeer, Izabela Sitkiewicz

  171. Focus Group Study of Hand Hygiene Practice among Healthcare Workers in a Teaching Hospital in Toronto, Canada

    Article • Infection Control, February 2010, Cambridge University Press

    Dr Allison McGeer

  172. Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2010, Springer Science + Business Media

    Dr Roberto G Melano, Dr Allison McGeer

  173. Health Care–Associated Clostridium difficile Infection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

    Article • Clinical Infectious Diseases, January 2010, Oxford University Press (OUP)

    Dr Allison McGeer, Dr Mark Miller

  174. High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from Canada

    Article • Antimicrobial Agents and Chemotherapy, January 2010, ASM Journals

    Dr Allison McGeer

  175. Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis

    Article • Proceedings of the National Academy of Sciences, January 2010, Proceedings of the National Academy of Sciences

    Dr Allison McGeer, Izabela Sitkiewicz

  176. Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience.

    Article • PLoS Currents, December 2009, PLOS

    Dr Allison McGeer

  177. Pneumococcal Pneumonia: Potential for Diagnosis through a Urinary Metabolic Profile

    Article • Journal of Proteome Research, December 2009, American Chemical Society (ACS)

    Dr Allison McGeer

  178. Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006

    Article • Antimicrobial Agents and Chemotherapy, November 2009, ASM Journals

    Dr Allison McGeer

  179. Towards the Photonic Nose: A Novel Platform for Molecule and Bacteria Identification

    Article • Advanced Materials, November 2009, Wiley

    Dr Allison McGeer

  180. Assessing the Impact of Intravenous Immunoglobulin in the Management of Streptococcal Toxic Shock Syndrome: A Noble but Difficult Quest

    Article • Clinical Infectious Diseases, November 2009, Oxford University Press (OUP)

    Dr Allison McGeer

  181. Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto

    Article • PLOS One, September 2009, PLOS

    Dr Allison McGeer

  182. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age

    Article • Vaccine, September 2009, Elsevier

    Dr Allison McGeer

  183. Infection with H274Y-positive influenza A (H1N1) is not associated with a change in nasopharyngeal Streptococcus pneumoniae colonization in patients

    Article • International Journal of Infectious Diseases, September 2009, Elsevier

    Dr Allison McGeer

  184. In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008

    Article • Journal of Antimicrobial Chemotherapy, July 2009, Oxford University Press (OUP)

    Dr Allison McGeer

  185. Characterization of Cefoxitin-Resistant Escherichia coli Isolates from Recreational Beaches and Private Drinking Water in Canada between 2004 and 2006

    Article • Antimicrobial Agents and Chemotherapy, April 2009, ASM Journals

    Dr Allison McGeer

  186. Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América

    Article • Clinical Infectious Diseases, April 2009, Oxford University Press (OUP)

    Dr Allison McGeer

  187. Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Article • Clinical Infectious Diseases, April 2009, Oxford University Press (OUP)

    Dr Allison McGeer

  188. Lignes directrices quant à la prise en charge des patientes en obstétrique chez lesquelles la présence du syndrome respiratoire aigu sévère (SRAS) est soupçonnée ou probable, et des nouveau-nés issus de ces patientes

    Article • Journal of Obstetrics and Gynaecology Canada, April 2009, Elsevier

    Dr Allison McGeer

  189. Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)

    Article • Journal of Obstetrics and Gynaecology Canada, April 2009, Elsevier

    Dr Allison McGeer

  190. Health Care–Associated Clostridium difficile Infection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study

    Article • Clinical Infectious Diseases, March 2009, Oxford University Press (OUP)

    Dr Allison McGeer, Dr Mark Miller

  191. Impact of a Mandatory Infection Control Education Program on Nosocomial Acquisition of Methicillin-ResistantStaphylococcus aureus

    Article • Infection Control, March 2009, Cambridge University Press

    Dr Allison McGeer

  192. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada

    Article • American Journal of Infection Control, February 2009, Elsevier

    Dr Allison McGeer, Dr Mark Miller

  193. CME Questions

    Article • Clinical Infectious Diseases, January 2009, Oxford University Press (OUP)

    Dr Allison McGeer

  194. Diagnostic Testing or Empirical Therapy for Patients Hospitalized with Suspected Influenza: What to Do?

    Article • Clinical Infectious Diseases, January 2009, Oxford University Press (OUP)

    Dr Allison McGeer

  195. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae

    Article • BMC Genomics, January 2009, Springer Science + Business Media

    Dr Allison McGeer

  196. The Effect of Universal Influenza Immunization on Mortality and Health Care Use

    Article • PLoS Medicine, October 2008, PLOS

    Mr Lawrence Svenson, Dr Allison McGeer

  197. The individual, environmental, and organizational factors that influence nurses' use of facial protection to prevent occupational transmission of communicable respiratory illness in acute care hospitals

    Article • American Journal of Infection Control, September 2008, Elsevier

    Dr Allison McGeer

  198. Characterization of Clostridium difficile Strains Isolated from Patients in Ontario, Canada, from 2004 to 2006

    Article • Journal of Clinical Microbiology, July 2008, ASM Journals

    Dr Allison McGeer

  199. Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America

    Article • PLOS One, July 2008, PLOS

    Dr Allison McGeer

  200. Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) Acquisition in Roommate Contacts of Patients Colonized or Infected With MRSA in an Acute-Care Hospital

    Article • Infection Control, July 2008, Cambridge University Press

    Dr Allison McGeer

  201. Dietary Intake of Elderly Living In Toronto Long-Term Care Facilities: Comparison with the Dietary Reference Intake: Response to Klevay

    Article • Rejuvenation Research, June 2008, Mary Ann Liebert Inc

    Dr Allison McGeer

  202. Reply to Chan‐Tack and Murray

    Article • Clinical Infectious Diseases, May 2008, Oxford University Press (OUP)

    Dr Allison McGeer

  203. Factors Associated With Acquisition of Vancomycin-Resistant Enterococci (VRE) in Roommate Contacts of Patients Colonized or Infected with VRE in a Tertiary Care Hospital

    Article • Infection Control, May 2008, Cambridge University Press

    Dr Allison McGeer

  204. A Cross-Sectional Study of Maternity Care Providers’ and Women’s Knowledge, Attitudes, and Behaviours Towards Influenza Vaccination During Pregnancy

    Article • Journal of Obstetrics and Gynaecology Canada, May 2008, Elsevier

    Dr Allison McGeer

  205. At the Threshold: Defining Clinically Meaningful Resistance Thresholds for Antibiotic Choice in Community‐Acquired Pneumonia

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Allison McGeer

  206. Impact of public vaccination programs on adult vaccination rates: Two examples from Ontario, Canada

    Article • Vaccine, March 2008, Elsevier

    Dr Allison McGeer

  207. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance

    Article • British Journal of Pharmacology, January 2008, Nature

    Dr Allison McGeer

  208. Neonatal group B streptococcal disease: Incidence, presentation, and mortality

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, January 2008, Taylor & Francis

    Dr Allison McGeer

  209. Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada

    Article • Clinical Infectious Diseases, December 2007, Oxford University Press (OUP)

    Dr Allison McGeer

  210. Antivirals and the Control of Influenza Outbreaks

    Article • Clinical Infectious Diseases, November 2007, Oxford University Press (OUP)

    Dr Allison McGeer

  211. Factors Associated With Critical-Care Healthcare Workers' Adherence to Recommended Barrier Precautions During the Toronto Severe Acute Respiratory Syndrome Outbreak

    Article • Infection Control, November 2007, Cambridge University Press

    Dr Allison McGeer

  212. Dietary Intake of Elderly Living in Toronto Long-Term Care Facilities: Comparison to the Dietary Reference Intake

    Article • Rejuvenation Research, September 2007, Mary Ann Liebert Inc

    Dr Allison McGeer

  213. Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals

    Article • Antimicrobial Agents and Chemotherapy, August 2007, ASM Journals

    Dr Allison McGeer

  214. RESPONSE LETTER TO DR. HEMILÄ

    Article • Journal of the American Geriatrics Society, August 2007, Wiley

    Dr Allison McGeer

  215. Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome

    Article • Journal of Virology, May 2007, ASM Journals

    Dr Allison McGeer

  216. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates

    Article • FEMS Microbiology Letters, May 2007, Oxford University Press (OUP)

    Dr Allison McGeer

  217. Invasive Pneumococcal Disease in Solid Organ Transplant Recipients?10-Year Prospective Population Surveillance

    Article • American Journal of Transplantation, May 2007, Wiley

    Dr Allison McGeer

  218. Comparative Genomics of Canadian Epidemic Lineages of Methicillin-Resistant Staphylococcus aureus

    Article • Journal of Clinical Microbiology, April 2007, ASM Journals

    Dr Allison McGeer

  219. Severe Acute Respiratory Syndrome (SARS) Coronavirus

    Article • Seminars in Respiratory and Critical Care Medicine, April 2007, Thieme Publishing Group

    Dr Allison McGeer

  220. Adverse Events Associated with High-Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2007, Wiley

    Dr Allison McGeer

  221. Alternative Methods of Estimating an Incubation Distribution

    Article • Epidemiology, March 2007, Wolters Kluwer Health

    Dr Allison McGeer

  222. Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization

    Article • Clinical Infectious Diseases, January 2007, Oxford University Press (OUP)

    Dr Allison McGeer

  223. Appropriate measures of influenza immunization program effectiveness

    Article • Vaccine, January 2007, Elsevier

    Dr Allison McGeer

  224. Effect of Multivitamin and Mineral Supplementation on Episodes of Infection in Nursing Home Residents: A Randomized, Placebo-Controlled Study

    Article • Journal of the American Geriatrics Society, January 2007, Wiley

    Dr Allison McGeer

  225. Guillain-Barré Syndrome After Influenza Vaccination in Adults

    Article • Archives of Internal Medicine, November 2006, American Medical Association (AMA)

    Dr Allison McGeer

  226. Verification of the IDI-MRSA Assay for Detecting Methicillin-Resistant Staphylococcus aureus in Diverse Specimen Types in a Core Clinical Laboratory Setting

    Article • Journal of Clinical Microbiology, October 2006, ASM Journals

    Dr Allison McGeer

  227. OVERDIAGNOSIS OF ASTHMA AND ITS RELATIONSHIP TO BODY MASS INDEX

    Article • CHEST Journal, October 2006, Elsevier

    Dr Allison McGeer

  228. Macrolide Resistance in Bacteremic Pneumococcal Disease: Implications for Patient Management

    Article • Clinical Infectious Diseases, August 2006, Oxford University Press (OUP)

    Dr Allison McGeer

  229. Accuracy of Healthcare Worker Recall and Medical Record Review for Identifying Infectious Exposures to Hospitalized Patients

    Article • Infection Control, July 2006, Cambridge University Press

    Dr Allison McGeer

  230. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household

    Article • Veterinary Microbiology, June 2006, Elsevier

    Dr Allison McGeer

  231. Cluster of Cases of Severe Acute Respiratory Syndrome Among Toronto Healthcare Workers After Implementation of Infection Control Precautions: A Case Series

    Article • Infection Control, May 2006, Cambridge University Press

    Dr Allison McGeer

  232. An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital

    Article • Veterinary Microbiology, April 2006, Elsevier

    Dr Allison McGeer

  233. Early diagnosis of SARS: lessons from the Toronto SARS outbreak

    Article • European Journal of Clinical Microbiology & Infectious Diseases, April 2006, Springer Science + Business Media

    Dr Allison McGeer

  234. Methicillin-Resistant Staphylococcus aureus in Canadian Aboriginal People

    Article • Infection Control, March 2006, Cambridge University Press

    Dr Allison McGeer

  235. Febrile respiratory illness in the intensive care unit setting: an infection control perspective

    Article • Current Opinion in Critical Care, February 2006, Wolters Kluwer Health

    Dr Allison McGeer

  236. Viable Group A Streptococci in Macrophages during Acute Soft Tissue Infection

    Article • PLoS Medicine, January 2006, PLOS

    Dr Allison McGeer

  237. Methicillin-resistant Staphylococcus aureus Colonization in Veterinary Personnel

    Article • January 2006, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  238. Coordinated Response to SARS, Vancouver, Canada

    Article • Emerging Infectious Diseases, January 2006, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  239. A survey of physician's attitudes regarding management of severe group A streptococcal infections

    Article • Scandinavian Journal of Infectious Diseases, January 2006, Taylor & Francis

    Dr Allison McGeer

  240. Methicillin-resistant Staphylococcus Aureus in Horses at a Veterinary Teaching Hospital: Frequency, Characterization, and Association with Clinical Disease

    Article • Journal of Veterinary Internal Medicine, January 2006, Wiley

    Dr Allison McGeer

  241. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 2005, Springer Science + Business Media

    Dr Allison McGeer

  242. Use of a Selective Enrichment Broth To Recover Clostridium difficile from Stool Swabs Stored under Different Conditions

    Article • Journal of Clinical Microbiology, October 2005, ASM Journals

    Dr Allison McGeer

  243. Clinical and Epidemiologic Features of Methicillin-Resistant Staphylococcus aureus in Elderly Hospitalized Patients

    Article • Infection Control, October 2005, Cambridge University Press

    Dr Allison McGeer

  244. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial

    Article • BMJ, September 2005, BMJ

    Dr Allison McGeer

  245. Genetic Diversity among Type emm28 Group A Streptococcus Strains Causing Invasive Infections and Pharyngitis

    Article • Journal of Clinical Microbiology, August 2005, ASM Journals

    Dr Allison McGeer

  246. Decreased Prevalence of Virulence Factors among Ciprofloxacin-Resistant Uropathogenic Escherichia coli Isolates

    Article • Journal of Clinical Microbiology, August 2005, ASM Journals

    Dr Allison McGeer

  247. Hospital-Acquired Invasive Group A Streptococcal Infections in Ontario, Canada, 1992-2000

    Article • Clinical Infectious Diseases, August 2005, Oxford University Press (OUP)

    Dr Allison McGeer

  248. Risk Factors for Pediatric Invasive Group A Streptococcal Disease

    Article • Emerging Infectious Diseases, July 2005, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  249. Modeling Transmission of Methicillin-Resistant Staphylococcus Aureus Among Patients Admitted to a Hospital

    Article • Infection Control, July 2005, Cambridge University Press

    Dr Allison McGeer

  250. Mosaic Prophages with Horizontally Acquired Genes Account for the Emergence and Diversification of the Globally Disseminated M1T1 Clone of Streptococcus pyogenes

    Article • Journal of Bacteriology, May 2005, ASM Journals

    Dr Allison McGeer, Dr Robert A Edwards

  251. Identification of a Progenitor of the CTX-M-9 Group of Extended-Spectrum β-Lactamases from Kluyvera georgiana Isolated in Guyana

    Article • Antimicrobial Agents and Chemotherapy, May 2005, ASM Journals

    Dr Allison McGeer

  252. Prevalence and Characterization of Invasive Isolates of Streptococcus pyogenes with Reduced Susceptibility to Fluoroquinolones

    Article • Antimicrobial Agents and Chemotherapy, May 2005, ASM Journals

    Dr Allison McGeer

  253. Detection of Airborne Severe Acute Respiratory Syndrome (SARS) Coronavirus and Environmental Contamination in SARS Outbreak Units

    Article • The Journal of Infectious Diseases, May 2005, Oxford University Press (OUP)

    Dr Allison McGeer

  254. Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections

    Article • Clinical Infectious Diseases, May 2005, Oxford University Press (OUP)

    Dr Allison McGeer

  255. Can Routine Laboratory Tests Discriminate between Severe Acute Respiratory Syndrome and Other Causes of Community‐Acquired Pneumonia?

    Article • Clinical Infectious Diseases, April 2005, Oxford University Press (OUP)

    Dr Allison McGeer

  256. Patient Contact Recall after SARS Exposure

    Article • Emerging Infectious Diseases, April 2005, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  257. Does isolation prevent the spread of methicillin-resistant Staphylococcus aureus?

    Article • Canadian Medical Association Journal, March 2005, Canadian Medical Association (CMA)

    Dr Allison McGeer

  258. Economic Evaluation of Oseltamivir Phosphate for Postexposure Prophylaxis of Influenza in Long-Term Care Facilities

    Article • Journal of the American Geriatrics Society, March 2005, Wiley

    Dr Allison McGeer

  259. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach

    Article • Scandinavian Journal of Infectious Diseases, March 2005, Taylor & Francis

    Dr Allison McGeer

  260. Beliefs and practices of Ontario midwives about influenza immunization

    Article • Vaccine, February 2005, Elsevier

    Dr Allison McGeer

  261. Nosocomial Acquisition of Methicillin-Resistant Staphylococcus aureus During an Outbreak of Severe Acute Respiratory Syndrome

    Article • Infection Control, February 2005, Cambridge University Press

    Dr Allison McGeer

  262. Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses

    Article • Journal of the American Veterinary Medical Association, February 2005, American Veterinary Medical Association (AVMA)

    Dr Allison McGeer

  263. Compliance and psychological impact of the quarantine experience during SARS

    Article • January 2005, American Psychological Association (APA)

    Dr Allison McGeer

  264. SARS outbreak in the Greater Toronto Area: the emergency department experience

    Article • Canadian Medical Association Journal, November 2004, Canadian Medical Association (CMA)

    Dr Allison McGeer

  265. Adverse Effects of Amantadine and Oseltamivir Used During Respiratory Outbreaks in a Center for Developmentally Disabled Adults

    Article • Infection Control, November 2004, Cambridge University Press

    Dr Allison McGeer

  266. Complete Nucleotide Sequence of a 92-Kilobase Plasmid Harboring the CTX-M-15 Extended-Spectrum Beta-Lactamase Involved in an Outbreak in Long-Term-Care Facilities in Toronto, Canada

    Article • Antimicrobial Agents and Chemotherapy, September 2004, ASM Journals

    Dr Allison McGeer

  267. In Vitro Antimicrobial Susceptibilities of Streptococcus pneumoniae Clinical Isolates Obtained in Canada in 2002

    Article • Antimicrobial Agents and Chemotherapy, September 2004, ASM Journals

    Dr Allison McGeer

  268. Health Care Workers and the Initiation of Treatment for Latent Tuberculosis Infection

    Article • Clinical Infectious Diseases, September 2004, Oxford University Press (OUP)

    Dr Allison McGeer

  269. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operon

    Article • Journal of Antimicrobial Chemotherapy, July 2004, Oxford University Press (OUP)

    Dr Allison McGeer

  270. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections

    Article • Proceedings of the National Academy of Sciences, July 2004, Proceedings of the National Academy of Sciences

    Dr Allison McGeer

  271. Let Him Who Desires Peace Prepare for War: United States Hospitals and Severe Acute Respiratory Syndrome Preparedness

    Article • Clinical Infectious Diseases, July 2004, Oxford University Press (OUP)

    Dr Allison McGeer

  272. Clostridium difficile infection in hospitals: a brewing storm

    Article • Canadian Medical Association Journal, July 2004, Canadian Medical Association (CMA)

    Dr Allison McGeer

  273. Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins

    Article • Emerging Infectious Diseases, June 2004, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  274. Transmission and control of SARS

    Article • Current Infectious Disease Reports, June 2004, Springer Science + Business Media

    Dr Allison McGeer

  275. SARS in Healthcare Facilities, Toronto and Taiwan

    Article • Emerging Infectious Diseases, May 2004, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  276. Hospital Preparedness and SARS

    Article • Emerging Infectious Diseases, May 2004, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  277. Patterns of Handwashing Behavior and Visits to Patients on a General Medical Ward of Healthcare Workers

    Article • Infection Control, March 2004, Cambridge University Press

    Dr Allison McGeer

  278. News in Antimicrobial Resistance: Documenting the Progress of Pathogens

    Article • Infection Control, February 2004, Cambridge University Press

    Dr Allison McGeer

  279. SARS among Critical Care Nurses, Toronto

    Article • Emerging Infectious Diseases, February 2004, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  280. Facility-Level Correlates of Antimicrobial Use in Nursing Homes

    Article • Infection Control, February 2004, Cambridge University Press

    Dr Allison McGeer

  281. Severe Invasive Group a Streptococcal Infections

    Article • January 2004, Springer Science + Business Media

    Dr Allison McGeer

  282. Nutrition Risk Factors for Survival in the Elderly Living in Canadian Long-Term Care Facilities

    Article • Journal of the American Geriatrics Society, January 2004, Wiley

    Dr Allison McGeer

  283. SARS — One Year Later

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2003, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  284. Use of, Effectiveness of, and Attitudes Regarding Influenza Vaccine Among House Staff

    Article • Infection Control, November 2003, Cambridge University Press

    Dr Allison McGeer

  285. High Heart Rates at Anaerobic Threshold in Healthy Women

    Article • Archives of Internal Medicine, September 2003, American Medical Association (AMA)

    Dr Allison McGeer

  286. Invasive Group A Streptococcal Disease: Risk Factors for Adults

    Article • Emerging Infectious Diseases, August 2003, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  287. Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001

    Article • Antimicrobial Agents and Chemotherapy, July 2003, ASM Journals

    Dr Allison McGeer

  288. Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae : Redefining Fluoroquinolone Resistance

    Article • Emerging Infectious Diseases, July 2003, Centers for Disease Control and Prevention (CDC)

    Dr Allison McGeer

  289. Identification of Severe Acute Respiratory Syndrome in Canada

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2003, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  290. Is resistance futile?

    Article • Nature Medicine, April 2003, Springer Science + Business Media

    Dr Allison McGeer

  291. Clinical manifestations associated with the aberrant expression of the soluble granulocyte-macrophage colony-stimulating factor receptor in patients presenting with haematological malignancies

    Article • British Journal of Haematology, April 2003, Wiley

    Dr Allison McGeer

  292. Clinical and Epidemiologic Features of Group A Streptococcal Pneumonia in Ontario, Canada

    Article • Archives of Internal Medicine, February 2003, American Medical Association (AMA)

    Dr Allison McGeer

  293. Association of Human Leukocyte Antigen with Outcomes of Infectious Diseases: The Streptococcal Experience

    Article • Scandinavian Journal of Infectious Diseases, January 2003, Taylor & Francis

    Dr Allison McGeer

  294. Risk Factors for Resistance to Antimicrobial Agents among Nursing Home Residents

    Article • American Journal of Epidemiology, January 2003, Oxford University Press (OUP)

    Dr Allison McGeer

  295. Prospective Surveillance for Primary Bloodstream Infections Occurring in Canadian Hemodialysis Units

    Article • Infection Control, December 2002, Cambridge University Press

    Dr Allison McGeer

  296. Microbiologic findings and risk factors for antimicrobial resistance at myringotomy for tympanostomy tube placement—a prospective study of 601 children in Toronto

    Article • International Journal of Pediatric Otorhinolaryngology, December 2002, Elsevier

    Dr Allison McGeer

  297. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections

    Article • Nature Medicine, November 2002, Springer Science + Business Media

    Dr Allison McGeer

  298. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections

    Article • Nature Medicine, November 2002, Springer Science + Business Media

    Dr Allison McGeer

  299. Prevention of Invasive Group A Streptococcal Disease among Household Contacts of Case Patients and among Postpartum and Postsurgical Patients: Recommendations from the Centers for Disease Control and Prevention

    Article • Clinical Infectious Diseases, October 2002, Oxford University Press (OUP)

    Dr Allison McGeer, Professor Gregory C Gray

  300. Laboratory Characterization of Methicillin‐Resistant Staphylococcus aureus in Canadian Hospitals: Results of 5 Years of National Surveillance, 1995–1999

    Article • The Journal of Infectious Diseases, September 2002, Oxford University Press (OUP)

    Dr Allison McGeer

  301. Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains

    Article • International Journal of Antimicrobial Agents, August 2002, Elsevier

    Dr Allison McGeer

  302. Laboratory Contamination of Specimens with Quality Control Strains of Vancomycin-Resistant Enterococci in Ontario

    Article • Journal of Clinical Microbiology, July 2002, ASM Journals

    Dr Allison McGeer

  303. Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000

    Article • Antimicrobial Agents and Chemotherapy, May 2002, ASM Journals

    Dr Allison McGeer

  304. Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000

    Article • Antimicrobial Agents and Chemotherapy, May 2002, ASM Journals

    Dr Allison McGeer

  305. Activity of BMS-284756, a Novel Des-Fluoro(6) Quinolone, against Staphylococcus aureus, Including Contributions of Mutations to Quinolone Resistance

    Article • Antimicrobial Agents and Chemotherapy, April 2002, ASM Journals

    Dr Allison McGeer

  306. Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000

    Article • Journal of the American Geriatrics Society, April 2002, Wiley

    Dr Allison McGeer

  307. Severe Group A Streptococcal Soft-Tissue Infections in Ontario: 1992-1996

    Article • Clinical Infectious Diseases, February 2002, Oxford University Press (OUP)

    Dr Allison McGeer

  308. Quality and methods of developing practice guidelines

    Article • BMC Health Services Research, January 2002, Springer Science + Business Media

    Dr Martin O'Flaherty, Dr Allison McGeer, Professor David Torgerson

  309. Exploring the Pathogenesis of Necrotizing Fasciitis Due to Streptococcus pneumoniae

    Article • Scandinavian Journal of Infectious Diseases, January 2002, Taylor & Francis

    Dr Allison McGeer

  310. Annualized Incidence and Spectrum of Illness from an Outbreak Investigation of Bell’s Palsy

    Article • Neuroepidemiology, January 2002, Karger Publishers

    Dr Allison McGeer

  311. Prevalence and Mechanisms of Macrolide Resistance in Invasive and Noninvasive Group B Streptococcus Isolates from Ontario, Canada

    Article • Antimicrobial Agents and Chemotherapy, December 2001, ASM Journals

    Dr Allison McGeer

  312. Evidence for Superantigen Involvement in Severe Group A Streptococcal Tissue Infections

    Article • The Journal of Infectious Diseases, October 2001, Oxford University Press (OUP)

    Dr Allison McGeer

  313. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home

    Article • International Congress Series, October 2001, Elsevier

    Dr Allison McGeer

  314. Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals

    Article • Diagnostic Microbiology and Infectious Disease, September 2001, Elsevier

    Dr Lori L. Burrows, Dr Allison McGeer

  315. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation

    Article • The Pediatric Infectious Disease Journal, September 2001, Wolters Kluwer Health

    Dr Allison McGeer

  316. A Nosocomial Outbreak of Fluoroquinolone‐Resistant Streptococcus pneumoniae

    Article • Clinical Infectious Diseases, August 2001, Oxford University Press (OUP)

    Dr Allison McGeer

  317. Identifying research priorities on infections in older adults: proceedings of an interdisciplinary workshop

    Article • BMC Geriatrics, August 2001, Springer Science + Business Media

    Dr Allison McGeer

  318. Antibodies to Capsular Polysaccharides of Group B Streptococcus in Pregnant Canadian Women: Relationship to Colonization Status and Infection in the Neonate

    Article • The Journal of Infectious Diseases, August 2001, Oxford University Press (OUP)

    Dr Allison McGeer

  319. Evaluation of Susceptibility Testing To Detect Fluoroquinolone Resistance Mechanisms in Streptococcus pneumoniae

    Article • Antimicrobial Agents and Chemotherapy, June 2001, ASM Journals

    Dr Allison McGeer

  320. Antibiotic use in ontario facilities that provide chronic care

    Article • Journal of General Internal Medicine, June 2001, Springer Science + Business Media

    Dr Allison McGeer

  321. Oropharyngeal Candidiasis in Patients with Human Immunodeficiency Virus: Correlation of Clinical Outcome with In Vitro Resistance, Serum Azole Levels, and Immunosuppression

    Article • Clinical Infectious Diseases, June 2001, Oxford University Press (OUP)

    Dr Allison McGeer

  322. A 2 factor model helped to rule out early stage necrotising fasciitis

    Article • Evidence-Based Medicine, May 2001, BMJ

    Dr Allison McGeer

  323. A RANDOMIZED TRIAL TO MEASURE THE OPTIMAL ROLE OF THE PHARMACIST IN PROMOTING EVIDENCE-BASED ANTIBIOTIC USE IN ACUTE CARE HOSPITALS

    Article • International Journal of Technology Assessment in Health Care, April 2001, Cambridge University Press

    Dr Allison McGeer

  324. A Blinded Comparison of Three Laboratory Protocols for the Identification of Patients Colonized With Methicillin-Resistant Staphylococcus aureus

    Article • Infection Control, March 2001, Cambridge University Press

    Dr Allison McGeer

  325. Development of Minimum Criteria for the Initiation of Antibiotics in Residents of Long-Term–Care Facilities: Results of a Consensus Conference

    Article • Infection Control, February 2001, Cambridge University Press

    Dr Allison McGeer

  326. The Nature and Frequency of Blood Contacts Among Home Healthcare Workers

    Article • Infection Control, December 2000, Cambridge University Press

    Dr Allison McGeer

  327. Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases

    Article • Infection and Immunity, November 2000, ASM Journals

    Dr Allison McGeer

  328. Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing Home

    Article • Infection Control, November 2000, Cambridge University Press

    Dr Allison McGeer

  329. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection

    Article • European Journal of Immunology, November 2000, Wiley

    Dr Allison McGeer

  330. Etiology of community-acquired pediatric viral diarrhea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus outbreak, 1997 to 1998

    Article • The Pediatric Infectious Disease Journal, September 2000, Wolters Kluwer Health

    Dr Allison McGeer

  331. Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases

    Article • Infection and Immunity, June 2000, ASM Journals

    Dr Allison McGeer

  332. Cigarette Smoking and Invasive Pneumococcal Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2000, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  333. A Comparison of Model-Building Strategies for Lower Respiratory Tract Infection in Long-Term Care

    Article • Journal of Clinical Epidemiology, December 1999, Elsevier

    Dr Allison McGeer

  334. Prevention of Neural-Tube Defects

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1999, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  335. CLINICAL UTILITY OF QUANTITATIVE CYTOMEGALOVIRUS VIRAL LOAD DETERMINATION FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1

    Article • Transplantation, November 1999, Wolters Kluwer Health

    Dr Allison McGeer

  336. Molecular Characterization of a Nosocomial Outbreak of Human Respiratory Syncytial Virus on an Adult Leukemia/Lymphoma Ward

    Article • The Journal of Infectious Diseases, November 1999, Oxford University Press (OUP)

    Dr Allison McGeer

  337. Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: implications for GBS screening programs

    Article • Diagnostic Microbiology and Infectious Disease, November 1999, Elsevier

    Dr Allison McGeer

  338. Risk Factors for Pneumonia and Other Lower Respiratory Tract Infections in Elderly Residents of Long-term Care Facilities

    Article • Archives of Internal Medicine, September 1999, American Medical Association (AMA)

    Dr Allison McGeer

  339. Article • Nature Medicine, August 1999, Nature

    Dr Allison McGeer

  340. Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 1999, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  341. Influenza Vaccination in Long-Term–Care Facilities: Structuring Programs for Success

    Article • Infection Control, July 1999, Cambridge University Press

    Dr Allison McGeer

  342. Practical approach to the identification of clinically relevant Enterococcus species

    Article • Diagnostic Microbiology and Infectious Disease, July 1999, Elsevier

    Dr Allison McGeer

  343. Clinical Experience with 20 Cases of Group A Streptococcus Necrotizing Fasciitis and Myonecrosis: 1995 to 1997

    Article • Plastic & Reconstructive Surgery, May 1999, Wolters Kluwer Health

    Dr Allison McGeer

  344. Clinical Experience with 20 Cases of Group A Streptococcus Necrotizing Fasciitis and Myonecrosis: 1995 to 1997

    Article • Plastic & Reconstructive Surgery, May 1999, Wolters Kluwer Health

    Dr Allison McGeer

  345. Control of Transmission of Vancomycin-Resistant Enterococcus faecium in a Long-Term–Care Facility

    Article • Infection Control, May 1999, Cambridge University Press

    Dr Allison McGeer

  346. Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study

    Article • Clinical Infectious Diseases, April 1999, Oxford University Press (OUP)

    Dr Allison McGeer

  347. Elevated Serum Cytokines Are Associated with Cytomegalovirus Infection and Disease in Bone Marrow Transplant Recipients

    Article • The Journal of Infectious Diseases, February 1999, Oxford University Press (OUP)

    Dr Allison McGeer

  348. Skin and soft tissue infection

    Article • Current Opinion in Infectious Diseases, April 1998, Wolters Kluwer Health

    Dr Allison McGeer

  349. The rapid emergence of a new strain of MRSA in Ontario: Laboratory implications

    Article • Antimicrobics and Infectious Diseases Newsletter, April 1998, Elsevier

    Dr Allison McGeer

  350. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease

    Article • The Pediatric Infectious Disease Journal, April 1998, Wolters Kluwer Health

    Dr Allison McGeer

  351. Effect of Cytomegalovirus Infection on 1‐Year Mortality Rates Among Recipients of Allogeneic Bone Marrow Transplants

    Article • Clinical Infectious Diseases, March 1998, Oxford University Press (OUP)

    Dr Allison McGeer

  352. Varying Titers of Neutralizing Antibodies to Streptococcal Superantigens in Different Preparations of Normal Polyspecific Immunoglobulin G: Implications for Therapeutic Efficacy

    Article • Clinical Infectious Diseases, March 1998, Oxford University Press (OUP)

    Dr Allison McGeer

  353. Can pregnant women obtain their own specimens for group B streptococcus? A comparison of maternal versus physician screening. The Mount Sinai GBS Screening Group

    Article • Family Practice, October 1997, Oxford University Press (OUP)

    Dr Allison McGeer

  354. Invasive Infections Due to a Fish Pathogen, Streptococcus iniae

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 1997, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  355. Population-Based Surveillance for Group A Streptococcal Necrotizing Fasciitis: Clinical Features, Prognostic Indicators, and Microbiologic Analysis of Seventy-Seven Cases

    Article • The American Journal of Medicine, July 1997, Elsevier

    Dr Allison McGeer

  356. Invasive Group A Streptococcal Infections

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 1997, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  357. Novel Superantigens from Streptococcal Toxic Shock Syndrome Streptococcus pyogenes Isolates

    Article • January 1997, Springer Science + Business Media

    Dr Allison McGeer

  358. Superantigenic Activity Produced by Group A Streptococcal Isolates is Neutralized by Plasma from IVIG-Treated Streptococcal Toxic Shock Snydrome Patients

    Article • January 1997, Springer Science + Business Media

    Dr Allison McGeer

  359. Invasive Group A Streptococcal Infections in Ontario, Canada

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 1996, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  360. Tuberculosis Surveillance Practices in Long-Term Care Institutions

    Article • Infection Control, March 1995, JSTOR

    Dr Allison McGeer

  361. Tuberculosis Surveillance Practices in Long-Term Care Institutions

    Article • Infection Control, March 1995, Cambridge University Press

    Dr Allison McGeer

  362. Pharmacoeconomic Analysis of Empirical Therapy with Ceftazidime Alone or Combination Antibiotics for Febrile Neutropenia in Cancer Patients

    Article • PharmacoEconomics, January 1995, Springer Science + Business Media

    Dr Allison McGeer

  363. Influenza and Pneumococcal Vaccination and Tuberculin Skin Testing Programs in Long-Term Care Facilities: Where Do We Stand?

    Article • Infection Control, January 1995, JSTOR

    Dr Allison McGeer

  364. Influenza and Pneumococcal Vaccination and Tuberculin Skin Testing Programs in Long-Term Care Facilities: Where Do We Stand?

    Article • Infection Control, January 1995, Cambridge University Press

    Dr Allison McGeer

  365. HIV-Associated Lymphoma of the Gastrointestinal Tract: The University of Toronto AIDS-Lymphoma Study Group Experience

    Article • Leukemia & Lymphoma, January 1995, Taylor & Francis

    Dr Allison McGeer

  366. Diagnosis of Whipple's Disease by Molecular Analysis of Peripheral Blood

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1994, New England Journal of Medicine (NEJM/MMS)

    Dr Allison McGeer

  367. The Use of Molecular Typing Techniques in the Epidemiologic Investigation of Resistant Enterococci

    Article • Infection Control, August 1994, JSTOR

    Dr Allison McGeer

  368. The Use of Molecular Typing Techniques in the Epidemiologic Investigation of Resistant Enterococci

    Article • Infection Control, August 1994, Cambridge University Press

    Dr Allison McGeer

  369. Human Immunodeficiency Virus Transmission Between Surgeons and Patients in Orthopaedic Surgery

    Article • December 1993, Wolters Kluwer Health

    Dr Allison McGeer

  370. Recent advances in the management of infections in cancer patients

    Article • Critical Reviews in Oncology/Hematology, December 1993, Elsevier

    Dr Allison McGeer

  371. A Cluster of Surgical Wound Infections Due to Unrelated Strains of Group a Streptococci

    Article • Infection Control, May 1993, Cambridge University Press

    Dr Allison McGeer

  372. Reliability of interpretation of tuberculin testing in the elderly: Implications for practice

    Article • American Journal of Infection Control, April 1993, Elsevier

    Dr Allison McGeer

  373. Incorporating variations in the quality of individual randomized trials into meta-analysis

    Article • Journal of Clinical Epidemiology, March 1992, Elsevier

    Dr Allison McGeer

  374. Mechanisms of Glove Tears and Sharp Injuries Among Surgical Personnel

    Article • JAMA, September 1991, American Medical Association (AMA)

    Dr Allison McGeer

  375. Effect of an Automated Sink on Handwashing Practices and Attitudes in High-Risk Units

    Article • Infection Control, July 1991, JSTOR

    Dr Allison McGeer

  376. Effect of an Automated Sink on Handwashing Practices and Attitudes in High-Risk Units

    Article • Infection Control, July 1991, Cambridge University Press

    Dr Allison McGeer

  377. Definitions of infections

    Article • American Journal of Infection Control, June 1991, Elsevier

    Dr Allison McGeer

  378. Identification and management of salmonellosis in a newborn nursery

    Article • American Journal of Infection Control, April 1991, Elsevier

    Dr Allison McGeer

  379. Antibiotic prescribing patterns in long-term care facilities (LTCFs)

    Article • American Journal of Infection Control, April 1991, Elsevier

    Dr Allison McGeer

  380. Body temperature variation in elderly residents of long-term care facilities (LTCFs)

    Article • American Journal of Infection Control, April 1991, Elsevier

    Dr Allison McGeer

  381. Definitions of infection for surveillance in long-term care facilities

    Article • American Journal of Infection Control, February 1991, Elsevier

    Dr Allison McGeer

  382. Epidemiology of Needlestick Injuries in House Officers

    Article • The Journal of Infectious Diseases, October 1990, Oxford University Press (OUP)

    Dr Allison McGeer

  383. Surveillance for Quality Assessment: II. Surveillance for Noninfectious Processes: Back to Basics

    Article • Infection Control, January 1990, JSTOR

    Dr Allison McGeer

  384. Surveillance for Quality Assessment: II. Surveillance for Noninfectious Processes: Back to Basics

    Article • Infection Control, January 1990, Cambridge University Press

    Dr Allison McGeer

  385. The buffering capacity of the internal phase of thylakoids and the magnitude of the pH changes inside under flashing light

    Article • Biochimica et Biophysica Acta (BBA) - Bioenergetics, April 1979, Elsevier

    Dr Allison McGeer

  386. CALIBRATION OF FLASH INDUCED pH CHANGES INSIDE THYLAKOIDS AND KINETIC RESOLUTION OF PROTON EJECTION AND CONSUMPTION

    Article • January 1978, Elsevier

    Dr Allison McGeer

  387. Terminal Cross-linking of DNA Catalyzed by an Enzyme System Containing DNA Ligase, DNA Polymerase, and Exonuclease of Bacteriophage T7

    Article • Canadian Journal of Biochemistry, June 1974, Canadian Science Publishing

    Dr Allison McGeer

  388. The Effect of Universal Influenza Immunization on Mortality and Health Care Use

    Article • SciVee, Inc

    Mr Lawrence Svenson, Dr Allison McGeer